Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1987 Aug;117(2):237-41.
doi: 10.1111/j.1365-2133.1987.tb04122.x.

Nifedipine in the treatment of Raynaud's phenomenon in patients with systemic sclerosis

R H Meyrick Thomas  1 , M Rademaker, S M Grimes, A MacKay, I B Kovacs, E D Cook, S M Bowcock, J D Kirby
Affiliations
Clinical Trial

Nifedipine in the treatment of Raynaud's phenomenon in patients with systemic sclerosis

R H Meyrick Thomas et al. Br J Dermatol. 1987 Aug.

Abstract

A double-blind, placebo-controlled, cross-over trial of nifedipine 10 mg three times daily for 6 weeks, in 10 patients with Raynaud's phenomenon secondary to systemic sclerosis, is reported. A significant reduction in the duration of attacks of Raynaud's phenomenon was observed. Nifedipine therapy also reduced the number and severity of attacks of Raynaud's phenomenon and the development of new digital ulcers, and increased the digital blood flow, but none of these changes was statistically significant. No alteration in red blood cell deformability or leukocyte chemiluminescence was observed during nifedipine treatment.

PubMed Disclaimer

Publication types